Do We Need Alternative Screening Approaches for Cervical Cancer During Covid-19 Pandemic?

IF 0.8 Q4 REPRODUCTIVE BIOLOGY
M. Kurdoğlu, A. Khaki
{"title":"Do We Need Alternative Screening Approaches for Cervical Cancer During Covid-19 Pandemic?","authors":"M. Kurdoğlu, A. Khaki","doi":"10.15296/ijwhr.2021.43","DOIUrl":null,"url":null,"abstract":"health since it may allow the detection of not only precancerous lesions but also the cancers in their earliest stages, before the symptoms appear. However, the screening is not available for all types of cancer and has been highly recommended for cervical, breast, lung and colorectal cancers in certain ages and risk groups. Coronavirus disease 2019 (COVID-19) pandemic had a negative impact on cancer screening by making the access to preventive care facilities difficult. It has been stated that during COVID-19 pandemic between March and July 2020, particularly the women and individuals aged 30 to 49 years have postponed cancer screenings in Germany (1). Sharp decreases especially in the use of cervical cancer screening programs (2) may have led some cervical intraepithelial lesions to stay undetected in a potentially treatable stage of the cancerous progression. A two-month screening lock-down in Slovenia between March 12 and May 8, 2020 resulted in an 92% epidemic deficit of screening, as well as 70% and 68% decrease in follow-up and human papilloma virus (HPV) triage tests, respectively (3). During the stay-at-home order in California, approximately 80% decrease in cervical cancer screening rates compared with baseline was observed in the Kaiser Permanente Southern California (KPSC) network including 1.5 million women (4). National data in Italy showed that beside the lock-down, the significant reduction in the number of screening tests was also related to the fear of COVID-19, which resulted in the suspension of booked screenings and the reduction in adherence to screenings (5). The effects of disruption of cervical screening in COVID-19 pandemic can be mitigated by several approaches like HPV-based screening conducted from self-collected specimens. Such a reliable screening method may also allow to extend the screening intervals with longer reassurance against cervical cancer if it yields a negative result. The testing supported by telehealth Do We Need Alternative Screening Approaches for Cervical Cancer During Covid-19 Pandemic?","PeriodicalId":14346,"journal":{"name":"International Journal of Women's Health and Reproduction Sciences","volume":"12 1","pages":""},"PeriodicalIF":0.8000,"publicationDate":"2021-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Women's Health and Reproduction Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15296/ijwhr.2021.43","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"REPRODUCTIVE BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

health since it may allow the detection of not only precancerous lesions but also the cancers in their earliest stages, before the symptoms appear. However, the screening is not available for all types of cancer and has been highly recommended for cervical, breast, lung and colorectal cancers in certain ages and risk groups. Coronavirus disease 2019 (COVID-19) pandemic had a negative impact on cancer screening by making the access to preventive care facilities difficult. It has been stated that during COVID-19 pandemic between March and July 2020, particularly the women and individuals aged 30 to 49 years have postponed cancer screenings in Germany (1). Sharp decreases especially in the use of cervical cancer screening programs (2) may have led some cervical intraepithelial lesions to stay undetected in a potentially treatable stage of the cancerous progression. A two-month screening lock-down in Slovenia between March 12 and May 8, 2020 resulted in an 92% epidemic deficit of screening, as well as 70% and 68% decrease in follow-up and human papilloma virus (HPV) triage tests, respectively (3). During the stay-at-home order in California, approximately 80% decrease in cervical cancer screening rates compared with baseline was observed in the Kaiser Permanente Southern California (KPSC) network including 1.5 million women (4). National data in Italy showed that beside the lock-down, the significant reduction in the number of screening tests was also related to the fear of COVID-19, which resulted in the suspension of booked screenings and the reduction in adherence to screenings (5). The effects of disruption of cervical screening in COVID-19 pandemic can be mitigated by several approaches like HPV-based screening conducted from self-collected specimens. Such a reliable screening method may also allow to extend the screening intervals with longer reassurance against cervical cancer if it yields a negative result. The testing supported by telehealth Do We Need Alternative Screening Approaches for Cervical Cancer During Covid-19 Pandemic?
在Covid-19大流行期间,我们是否需要其他宫颈癌筛查方法?
健康,因为它不仅可以检测到癌前病变,还可以在症状出现之前检测到早期阶段的癌症。然而,这种筛查并不适用于所有类型的癌症,强烈建议对某些年龄和风险群体的宫颈癌、乳腺癌、肺癌和结直肠癌进行筛查。2019冠状病毒病(COVID-19)大流行对癌症筛查产生了负面影响,使人们难以获得预防性护理设施。据指出,在2020年3月至7月的COVID-19大流行期间,德国特别是30至49岁的女性和个人推迟了癌症筛查(1)。特别是宫颈癌筛查计划的使用急剧减少(2),可能导致一些宫颈上皮内病变在癌症进展的潜在可治疗阶段未被发现。斯洛文尼亚在2020年3月12日至5月8日期间进行了为期两个月的筛查封锁,导致筛查的流行病缺口达到92%,随访和人乳头瘤病毒(HPV)分诊检测分别减少了70%和68%(3)。在包括150万名妇女在内的南加州凯撒医疗机构(KPSC)网络中,与基线相比,宫颈癌筛查率下降了约80%(4)。意大利的国家数据显示,除了封锁之外,筛查测试数量的显著减少也与对COVID-19的恐惧有关。这导致预约筛查暂停,筛查依从性下降(5)。在COVID-19大流行期间,宫颈筛查中断的影响可以通过几种方法减轻,例如从自我收集的样本中进行基于hpv的筛查。如果检测结果为阴性,这种可靠的筛查方法还可以延长筛查间隔,使患者更放心地预防宫颈癌。在Covid-19大流行期间,我们需要其他宫颈癌筛查方法吗?
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.60
自引率
14.30%
发文量
8
期刊介绍: All kind of knowledge contributing to the development of science by its content, value, level and originality will be covered by IJWHR. Problems of public health and their solutions are at the head of the windows opening us to the world. The "International Journal of Women''s Health and Reproduction Sciences” is a modern forum for scientific communication, covering all aspects women health and reproduction sciences, in basic and clinical sciences, mainly including: -Medical Education in Women Health and Reproduction Sciences -Cardiology in Women Health-Related Reproductive Problems -Sports Medicine in Women Health and Reproduction Sciences -Psychiatry in Women Health-Related Reproductive Problems -Antioxidant Therapy in Reproduction Medicine Sciences -Nutrition in Women Health and Reproduction Sciences -Defense Androgen and Estrogen -Fertility and Infertility -Urogynecology -Endometriosis -Endocrinology -Breast Cancer -Menopause -Puberty -Eroticism -Pregnancy -Preterm Birth -Vaginal Diseases -Sex-Based Biology -Surgical Procedures -Nursing in Pregnancy -Obstetrics/Gynecology -Polycystic Ovary Syndrome -Hyperandrogenism in Females -Menstrual Syndrome and Complications -Oncology of Female Reproductive Organs -Traditional Medicine in Women Reproductive Health -Ultrasound in Women Health Reproduction sciences -Stem Cell Research In Women Reproduction Sciences -Complementary Medicine in Women Reproductive Health -Female Sexual Dysfunction: Pathophysiology & Treatment
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信